IRIS
BRUGNOLO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.911
AS - Asia 41
SA - Sud America 3
NA - Nord America 1
Totale 11.956
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.910
CN - Cina 37
SG - Singapore 3
BR - Brasile 2
EC - Ecuador 1
ID - Indonesia 1
RU - Federazione Russa 1
US - Stati Uniti d'America 1
Totale 11.956
Salva come PNG Salva come JPEG
Città #
Genova 6.358
Genoa 3.413
Rapallo 1.189
Vado Ligure 913
Bordighera 34
Beijing 16
Milan 2
Ashburn 1
Loja 1
São Paulo 1
Uberlândia 1
Totale 11.929
Salva come PNG Salva come JPEG
Nome #
An updated Italian normative dataset for the Stroop color word test (SCWT) 214
A normative study of the Italian printed word version of the free and cued selective reminding test 198
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 190
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 181
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 178
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 176
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 170
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 160
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 158
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 156
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 154
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 152
Cortical sources of awake scalp EEG in eating disorders 151
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 151
Parkinson’s Disease Sleep Scale 2: application in an Italian population 151
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 150
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 146
What predicts cognitive decline in de novo Parkinson's disease? 146
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 145
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 142
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 142
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 142
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 141
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 139
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. 137
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 135
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 134
Early identification of MCI converting to AD: a FDG PET study 133
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 133
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 132
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 131
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 130
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 129
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 128
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 128
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 127
99mTc-HMPAO and 99mTc-ECD brain distribution correlates differently with verbal memory performance in Alzheimer’s disease patients 127
The Von Restorff effect in ageing and Alzheimer's disease. 127
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 127
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 126
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 125
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 123
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 122
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 122
Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes 122
Correlazioni SPECT-neuropsicologia nella malattia di Alzheimer iniziale 121
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 121
The value of SPECT in detecting Alzheimer-type neurodegeneration in mild cognitive impairment 117
MCI patients declining and not declining at mid-term follow-up: FDG PET findings. Annual Congress of the European Association of Nuclear Medicine 114
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 114
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 113
Cognitive function in patients with carotid stenosis: preliminary data on the use of the WAIS-R. 112
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 112
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 107
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 107
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic disease Clin Exp Rheumatol 107
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 107
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 105
Do we need a 99mTc-ECD template for SPM SPECT studies? 103
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 102
Mapping memory impairment and conversion patterns in aMCI patients: a combined VBM and PET study 102
MMSE factorial analysis in Alzheimer’s disease. 101
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 101
Dehydroepiandrosterone sulphate and its correlation with clinical and hormonal parameters in eating disorders. 99
SPECT-Memory correlation in very mild Alzheimer’s disease. Effect of correlation for the severity of global cognitive impairment. 99
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 99
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 98
Cognitive correlates of nigrostriatal dysfunction in de novo Parkinson’s disease (PD) 98
Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. 98
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 96
Metabolic Networks Involved in Cognitive Reserve in Prodromal Alzheimer's Disesase (pAD): A European Alzheimer's Disease Consortium (EADC) Project 94
The 16 item-printed word version of the free and cued selective reminding test (FCSRT): normal values in an italian population 94
Principal component analysis of FDG PET in amnestic MCI 92
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 91
The need of appropriate brain spect templates for spm comparisons 88
Principal component analysis of FDG PET in amnestic MCI 87
Cortical sources of awakening scalp EEG in eating disorders. 87
Consistency of neuropsychiatric syndromes across dementias: Results from the european alzheimer disease consortium. Part ii 87
Integrated neurophysiological approach to Parkinson’s disease: preliminary data. 85
Manuale del Caregiver – Per chi si prende cura della persona malata di Alzheimer 83
Neuroprogression as an illness trajectory in bipolar disorder: A selective review of the current literature 83
Funzioni attentive nell’anoressia nervosa: dati neurofisiologici preliminar 82
The visual search test: analysis of sensitivity of the global score and of the three items in mild Alzheimer’s disease 82
Semantic memory impairment and geographic space recognition in Alzheimer’s disease 81
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 80
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 79
The organization of the neuropsychiatric "macro"- UVA at IRCCS AOU "San Martino-IST", Genova. 78
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 78
Is Euro a cognitive chellenge for the elderly? 77
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 75
Evidence of posterior cortical dysfunction in de novo, drug-naïve Parkinson’s disease (PD) 75
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 74
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 74
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 72
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era 71
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 71
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 71
The Stroop color and word test (SCWT): preliminary normal data in an Italian population 70
null 70
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 69
Totale 11.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.308
article - articoli 33.008
book - libri 0
conference - conferenze 7.675
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 625
Totale 82.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021524 0 0 0 65 26 54 56 57 57 75 64 70
2021/20221.226 32 66 114 151 52 83 67 256 50 116 50 189
2022/20231.355 102 95 21 147 211 222 4 116 248 18 148 23
2023/2024785 44 104 10 91 68 139 52 42 40 22 53 120
2024/20252.335 82 164 52 160 277 280 230 358 111 114 247 260
2025/20261.154 557 141 211 245 0 0 0 0 0 0 0 0
Totale 12.100